RecruitingNCT07026240

Post-operative Monitoring of Gastric Cancer

Post-operative Monitoring of Gastric Cancer Using Circulating DNA in Blood Samples


Sponsor

Suzhou Huhu Health & Technology Inc.

Enrollment

258 participants

Start Date

Feb 18, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study is to determine the performance of non-invasive new multi-target biomarkers in the post-operative monitoring of gastric cancer.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting data from patients who have stomach discomfort and are being evaluated or treated at a gastric surgery clinic, to better understand stomach conditions and cancer outcomes after surgery. **You may be eligible if...** - You are 18 or older - You have stomach discomfort and are being seen at the Gastric Surgery Department at the study center - You have or will have a gastroscopy (camera examination of the stomach) or tissue biopsy at this center - You can understand and sign the consent form yourself **You may NOT be eligible if...** - You have serious heart, liver, kidney, or mental health conditions - You have been diagnosed with any other type of cancer previously - You are known to have HIV or related immune conditions - You are taking targeted therapies, immunosuppressants, or biological agents - You cannot provide sufficient samples for the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTDNA test

a new non-invasive detection method for postoperative monitoring of gastric cancer in the blood


Locations(1)

Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07026240


Related Trials